IT1204906B - Soluzioni pronte iniettabili contenenti un glicoside antraciclinico antitumorale - Google Patents

Soluzioni pronte iniettabili contenenti un glicoside antraciclinico antitumorale

Info

Publication number
IT1204906B
IT1204906B IT20917/86A IT2091786A IT1204906B IT 1204906 B IT1204906 B IT 1204906B IT 20917/86 A IT20917/86 A IT 20917/86A IT 2091786 A IT2091786 A IT 2091786A IT 1204906 B IT1204906 B IT 1204906B
Authority
IT
Italy
Prior art keywords
anthracyclinic
glycoside
cancer
ready
injectable solutions
Prior art date
Application number
IT20917/86A
Other languages
English (en)
Other versions
IT8620917A0 (it
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1204906(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of IT8620917A0 publication Critical patent/IT8620917A0/it
Application granted granted Critical
Publication of IT1204906B publication Critical patent/IT1204906B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IT20917/86A 1985-08-02 1986-06-26 Soluzioni pronte iniettabili contenenti un glicoside antraciclinico antitumorale IT1204906B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (2)

Publication Number Publication Date
IT8620917A0 IT8620917A0 (it) 1986-06-26
IT1204906B true IT1204906B (it) 1989-03-10

Family

ID=10583216

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20917/86A IT1204906B (it) 1985-08-02 1986-06-26 Soluzioni pronte iniettabili contenenti un glicoside antraciclinico antitumorale

Country Status (34)

Country Link
US (1) US4946831A (it)
JP (1) JPH0655667B2 (it)
KR (1) KR920001773B1 (it)
CN (1) CN1064531C (it)
AT (1) AT397463B (it)
BE (1) BE905202A (it)
BG (1) BG60425B2 (it)
CA (1) CA1291037C (it)
CH (2) CH690490C2 (it)
CS (1) CS277561B6 (it)
CY (1) CY1592A (it)
DE (1) DE3621844C2 (it)
DK (1) DK167557B1 (it)
ES (1) ES8801580A1 (it)
FI (1) FI86800C (it)
FR (1) FR2585569B1 (it)
GB (2) GB8519452D0 (it)
GR (1) GR861556B (it)
HK (1) HK93990A (it)
HU (1) HU196123B (it)
IE (1) IE59297B1 (it)
IL (1) IL79129A (it)
IT (1) IT1204906B (it)
NL (2) NL191507C (it)
NO (1) NO170913C (it)
NZ (1) NZ216604A (it)
PH (1) PH22332A (it)
PT (1) PT82865B (it)
RU (2) RU1837883C (it)
SE (1) SE466383C (it)
SG (1) SG80690G (it)
UA (1) UA29383C2 (it)
YU (1) YU44788B (it)
ZA (1) ZA864792B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
EP1283044A3 (en) * 1986-12-05 2003-05-14 Pharmacia Italia S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
DE68905577T2 (de) * 1988-12-05 1993-07-01 Bristol Myers Squibb Co Doxorubicin-loesungen.
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
ATE195526T1 (de) * 1996-12-16 2000-09-15 Pharmachemie Bv Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin
BR9713661A (pt) 1996-12-30 2000-10-24 Battelle Memorial Institute Formulação e método para o tratamento de neoplasmas por inalação
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
US20140378404A1 (en) * 2011-10-25 2014-12-25 Nektar Therapeutics Treatment of Patients Suffering from Cancer
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
EP1283044A3 (en) * 1986-12-05 2003-05-14 Pharmacia Italia S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

Also Published As

Publication number Publication date
US4946831A (en) 1990-08-07
CS277561B6 (en) 1993-03-17
JPH0655667B2 (ja) 1994-07-27
IT8620917A0 (it) 1986-06-26
CH690490C2 (de) 2000-09-29
FR2585569A1 (fr) 1987-02-06
AT397463B (de) 1994-04-25
CY1592A (en) 1992-04-03
NO170913C (no) 2003-10-10
DE3621844A1 (de) 1987-03-05
RU2110263C1 (ru) 1998-05-10
SE466383B (sv) 1992-02-10
FI862629A0 (fi) 1986-06-19
SE466383C (sv) 1995-10-19
KR870001828A (ko) 1987-03-28
NO862587L (no) 1987-02-03
BE905202A (fr) 1987-02-02
ATA176886A (de) 1993-09-15
CA1291037C (en) 1991-10-22
YU44788B (en) 1991-02-28
CS470886A3 (en) 1992-11-18
BG60425B2 (bg) 1995-03-31
CH668911C1 (de) 2000-05-31
GB8519452D0 (en) 1985-09-11
PT82865B (pt) 1989-01-17
GB2178311A (en) 1987-02-11
NL300011I1 (nl) 2000-10-02
SG80690G (en) 1990-11-23
HU196123B (en) 1988-10-28
IL79129A0 (en) 1986-09-30
NO862587D0 (no) 1986-06-26
RU1837883C (ru) 1993-08-30
NL191507B (nl) 1995-04-18
IE861598L (en) 1987-02-02
SE8602743D0 (sv) 1986-06-19
NZ216604A (en) 1989-10-27
IL79129A (en) 1992-03-29
FI862629A (fi) 1987-02-03
HK93990A (en) 1990-11-23
NL191507C (nl) 2000-02-16
FR2585569B1 (fr) 1990-01-19
DK167557B1 (da) 1993-11-22
AU5885886A (en) 1987-02-12
GB8614800D0 (en) 1986-07-23
ES556291A0 (es) 1988-02-16
ZA864792B (en) 1988-02-24
ES8801580A1 (es) 1988-02-16
AU598197B2 (en) 1990-06-21
CH668911A5 (de) 1989-02-15
DE3621844C2 (de) 1994-02-17
HUT42326A (en) 1987-07-28
NL8601698A (nl) 1987-03-02
PT82865A (en) 1986-07-01
KR920001773B1 (ko) 1992-03-02
UA29383C2 (uk) 2000-11-15
GB2178311B (en) 1989-10-11
CN1064531C (zh) 2001-04-18
DK306286A (da) 1987-02-03
YU103586A (en) 1988-04-30
FI86800C (fi) 1999-10-28
SE8602743L (sv) 1987-02-03
GR861556B (en) 1986-10-17
DK306286D0 (da) 1986-06-27
PH22332A (en) 1988-07-29
IE59297B1 (en) 1994-02-09
NO170913B (no) 1992-09-21
CN86104283A (zh) 1987-01-28
JPS6248629A (ja) 1987-03-03
FI86800B (fi) 1992-07-15

Similar Documents

Publication Publication Date Title
DK17685D0 (da) Glycosidderivater
FI864467A0 (fi) Brandhaerdig vaeggkonstruktion.
NO2000009I1 (no) Exemestane
IT1204906B (it) Soluzioni pronte iniettabili contenenti un glicoside antraciclinico antitumorale
FR2590799B1 (fr) Seringue
DE3675777D1 (de) Einspritzvorrichtung.
DK240386A (da) Morphinanderivater
IT1201163B (it) Iniettore
DE3675674D1 (de) Alkyl-tert.-alkyl-ether enthaltende gum-freie kraftstoff-komponenten.
DK304286D0 (da) Saccharider
IT8722869A0 (it) Soluzioni iniettabili pronte all'uso contenenti un glicoside antraciclinico antitumorale.
DK605286A (da) Braendselsbriketter
ES288629Y (es) Jeringa
ES286789Y (es) Mecanismo inyector
KR870002155U (ko) 포도당 주입기
DK439486A (da) Glycosidiske forbindelser
ES276839Y (es) Jeringuilla
BR8406387A (pt) Seringa
DK51885D0 (da) Glycosylerede insulinderivater
KR860013013U (ko) 주사기
KR860009463U (ko) 세척기
MX9203578A (es) Soluciones inyectables que contienen glicosidos de antraciclina tumorales.
SE8402858D0 (sv) Ampull
KR860000465U (ko) 연적이 일체로된 벼루
MX159559A (es) Un inyector

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970628

MED Supplementary protection certificate for pharmaceutical products: no action taken

Free format text: CCP 702, 20000719; PHARMACIA & UPJOHN S.P.A.